4 rue Pierre Fontaine
91000 Evry-Courcouronnes – France
Contact : email@example.com
Radhia M’kacher : Présidente directrice générale
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.
Our academic research developed over 20 years reliable, sensitive and automated methods to detect DNA damage. Cell Environment was created to transfer these techniques into the clinics.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Cell Environment developed a high throughput genomic cytogenetic approach based on a very small amount of samples. This process associates telomere quantification to the analysis of chromosomal aberrations and the detection of chromosomal instability.
This approach is a break with the existent techniques. In order to transfer this approach in the clinics, we developed the kits of telomere and centromere staining as well as the software for automated analysis.
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
The first flagship products resulting from this innovation are
A validation of the approach was performed against clinical cytogenetics. A patent has been filed. The company has been approved as an R&D provider since 2017.
Cell Environment has started the industrialization and commercialization phase and we are looking for partners for the distribution of kits and funds to make our solution more relevant.
In same field
CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.Discover
Research & development for an in vitro diagnostic tool for endometriosisDiscover
SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.Discover
Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.Discover
Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.Discover
Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.Discover
– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodiesDiscover
Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell DiseaseDiscover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.Discover
AgenT is developing an unprecedented blood test to identify patients with Alzheimer's disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer's disease.Discover